Incannex Healthcare Inc. 8-K

What Happened Incannex Healthcare Inc. announced on January 15, 2026 (via an 8-K filing) that it won a Research and Development Award for its obstructive sleep apnea (OSA) program in the 2025 Clinical Trials Arena Excellence Awards. The company attached a press release announcing the award as Exhibit 99.1 to the filing, which is incorporated by reference.

Key Details

• Award: Research and Development Award for the company’s obstructive sleep apnea program (2025 Clinical Trials Arena Excellence Awards).
• Filing date: 8-K filed January 15, 2026 (Item 8.01 Other Events).
• Press release: Included as Exhibit 99.1 and incorporated by reference in the 8-K.
• The 8-K does not report any financial results, management changes, or other operational disclosures tied to the award.

Why It Matters An industry award publicly recognizes Incannex’s R&D work on obstructive sleep apnea, providing third‑party validation and potential visibility in the clinical and investor communities. The filing does not disclose any direct financial impact, revenue change, or operational shifts related to the award; investors should treat this as a positive development for program reputation but not a financial disclosure.